Publications

 

  1. Thomas IL, Nicklin JL, Pollock H, Faulkner K. Evaluation of a Maternity Cushion (Ozzlo Pillow) for Backache and Insomnia in Late Pregnancy.  Aust NZ J Obstet Gynaecol 1989; 29; 133-138.
  2. Nicklin JL. Systemic Lupus Erythematous and Pregnancy at Royal Women’s Hospital, Brisbane 1979 – 1989.  Aust NZ J Obstet Gynaecol 1991; 31: 128-133.
  3. Nicklin JL, Wright RG, Bell JR, Samaratunga H, Cox NC, Ward BG. A Clinicopathological Study of Adenocarcinoma in Situ of the Cervix.  The Influence of Cervical HPV Infection and Other Factors, and the Role of Conservative Surgery.  Aust NZ J Obstet Gynaecol 1991; 31: 179-193.
  4. Nicklin JL, van Eijkeren MA, Athanasatos P, Wain GV, Hacker NF. A comparison of ovarian cyst aspirate cytology and histology. The case against aspiration of cystic pelvic masses. Aust NZ J Obstet Gynaecol 1994;34:546-549.      
  5. Nicklin JL, Hacker NF, Heintze SW, van Eijkeren M, Durham NJ. An anatomical study of inguinal lymph node topography and clinical implications for the surgical management of vulval cancer. Int J Gynecol Cancer 1995;5:128-133.
  6. Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma.  Int J Gynecol Cancer 1995;5:250-256.
  7. Nicklin JL ‘Letter of Response’ to a ‘Letter to the Editor’ regarding paper ‘A comparison of ovarian cyst aspirate cytology and histology.  The case against aspiration of cystic pelvic masses.’  Aust NZ J Obstet Gynaecol 1995;35:234-235.
  1. Nicklin JL, Copeland LJ, O’Toole RV, Lewandowski GS, Vaccarello L, Havenar LP. Splenectomy as part of cytoreductive surgery for ovarian carcinoma. Gynecol Oncol  1995,58:244-247.
  1. Buttini M, Nicklin JL, Crandon A. Low malignant potential ovarian tumours: A review of 175 consecutive cases.  Aust NZ J Obstet Gynaecol 1997;37:100-103.
  1. Jafri NH, Neimann TH, Nicklin JL, Copeland LJ. A carcinoid tumor of the broad ligament.  Obstet Gynecol 1998;92(4) Part 2 Suppl. S:708.
  2. Nicklin JL, Perrin L, Philips G. Radical Surgery for Endometriosis.  Aust NZ J Obstet Gynaecol 1999;39:68-74.
  1. Perrin LC, Low J, Nicklin JL, Ward BG, Crandon AJ. Fertility and Ovarian Function After Conservative Surgery for Germ Cell Tumours of the Ovary.  Aust NZ J Obstet Gynaecol 1999;39:243-248.
  1. Nicklin JL, Perrin LC, Crandon AJ, Ward BG.  Microinvasive Adenocarcinoma of the Cervix.  Aust NZ J Obstet Gynaecol  1999;39:4:411-413.
  1. Petersen RW, Quinlivan JA, Casper G, Nicklin JL. Endometrial adenocarcinoma – Presenting pathology is a poor guide to surgical management.  Aust NZ J Obstet Gynaecol 2000;40:191-194.
  2. Nicklin JL, Petersen RW. Stage 3B Adenocarcinoma of the Endometrium.  A Clinicopathologic Study.  Gynecol Oncol  2000;78:203-207.
  3. Ng TY, Perrin LC, Nicklin JL, Cheuk R, Crandon AJ. Local Recurrence in High-Risk Node-Negative Stage I Endometrial Carcinoma Treated with Postoperative Vaginal Vault Brachytherapy.  Gyncol Oncol 2000;79:490-494.
  4. Ng TY, Nicklin JL, Perrin LC, Cheuk R, Crandon AJ. Postoperative Vaginal Vault Brachytherapy for Node-Negative Stage II (Occult) Endometrial Carcinoma. Gyncol Oncol 2001;81:193-195.
  5. Obermair A, Koller S, Crandon AJ, Perrin L, Nicklin JL. Primary Bartholin gland carcinoma: a report of seven cases. Aust NZ J Obstet Gynaecol  2001;41:78-81.
  6. Obermair A, Geramou M, Tripcony L, Nicklin JL, Perrin L, Crandon AJ. Peritoneal cytology: impact on disease-free survival in clinical stage 1 endometrioid adenocarcinoma of the uterus.  Cancer Lett 2001;164(1):105-110.
  7. Obermair A, Taylor KH, Janda M, Nicklin JL, Crandon AJ, Perrin L. Primary fallopian tube carcinoma: The Queensland experience.  Int J Gynecol Cancer 2001;11:69-72.
  8. Ng TY, Perrin LC, Nicklin JL, Cheuk R, Crandon AJ. Letter of Response’ to a ‘Letter to the Editor’ regarding paper ‘Local Recurrence in High-Risk Node-Negative Stage I Endometrial Carcinoma Treated with Postoperative Vaginal Vault Brachytherapy.’ Gyncol Oncol 2001:82;409.
  1. Nicklin JL, Perrin L, Obermair A, McConachie I, Cominos D. The Significance of Psammoma Bodies on Cervical Cytology Smears.  Gyncecol Oncol 2001:83;6-9.
  1. Quinlivan JA, Petersen RW, Nicklin JL. Accuracy of frozen section for the operative management of endometrial cancer.  Brit J Obstets Gynaecol  2001;108:798-803.
  2. Dong Y, Kaushal A, Bui L, Chu S, Fuller PJ, Nicklin JL, Samaratunga H, Clements JA. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.  Clin Cancer Res 2001;7:2363-71.
  3. Obermair A, Cheuk R, Horwood K, Janda M, Bachtiary B, Schwanzelberger B, Stoiber A, Nicklin JL, Perrin LC, Crandon AJ. Impact of Hemoglobin Levels Before and During Concurrent Chemoradiotherapy on the Response of Treatment in Patients with Cervical Carcinoma.  Cancer 2001;92:903-908.
  4. Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, Perrin LC, Ward BG, Crandon AJ. Safety and Efficacy of Low Anterior Resection en bloc as Part of Cytoreductive Surgery for Patients with Ovarian Cancer.  Gynecol Oncol 2001;83:15-120.
  5. Preyer O, Obermair A, Formann, Schmid W, Perrin LC, Ward BG, Crandon AJ, Nicklin JL. The Impact of Positive Peritoneal Washings and Serosal and Adnexal Involvement in Patients with Stage IIIA Uterine Cancer. Gynecol Oncol 2002;86:269-273.
  6. Land R, Perrin L, Nicklin J. Evaluation of restaging in clinical stage 1A low malignant potential ovarian tumours. Aust NZ J Obstet Gynaecol 2002;42:379-382.
  7. Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA. Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers.  Clin Cancer Res 2003;9(5):1710-1720.
  8. Frazer IH, Leggatt K, Matsumoto R, De Kluyver R, Quinn M, Nicklin JL, Tan J, Perrin L, Ng P, O’Connor V, White O, Wendt N, Martin J, Mitchell SV, McKenzie A, Crowley S, Edwards S, Maher D. Immunotherapy for HPV associated pre-cancer.  Cancer Immunity 2003; 3Suppl1:25.URL
  9. Obermair A, Cheuk R, Horwood K, Neudorfer M, Janda M, Giannis G, Nicklin J, Perrin L, Crandon AJ. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival.  Int J Gynecol Cancer 2003;13:633-639.
  10. Frazer IH, Quinn M, Nicklin JL, Tan J, Perrin LC, Ng P, O’Connor VM, White O, Wendt N, Martin J, Cowley JM, Edwards SJ, McKenzie AW, Mitchell SV, Maher DW, Pearse MJ, Masser RL. Phase I study of HPV-16 specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia.  Vaccine 2004;23(2):172-81
  11. Otton GR, Nicklin JL, Dickie GJ, Niedetzky P, Tripcony L, Perrin LC, Crandon AJ. Early-Stage vaginal carcinoma – an analysis of 70 patients. Int J Gynecol Cancer 2004;14:304-310.
  12. Lataifeh I, Nascimento MC, Nicklin JL, Perrin LC, Crandon AJ, Obermair A. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol 2004;95:701-705.
  13. Janda M, Obermair A, Cella D, Perrin LC, Nicklin JL, Ward BG, Crandon AJ, Trimmel M. The functional assessment of cancer-vulvar: Reliability and validity.  Gynecol Oncol 2005;97:568-575
  14. Garrett AJ, Nicklin JL, Land R. The use of an overlay autogenous tissue (OAT) patch to control intra-operative haemorrhage of the spleen.  Gynecol Oncol 2005;99:225-227.
  15. Paravasivam S, Tripcony L, Crandon A, Quinn M, Hammond I, Marsden D, Proietto A, Davy M, Carter J, Nicklin J, Perrin L, Obermair A. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.  J Clin Oncol 2005 Sep 1;23(25):5938-42.
  16. Garrett AJ, Nascimento MC, Nicklin JL, Perrin LC, Obermair A. Total laparoscopic hysterectomy:  The Brisbane learning curve. Aust NZ J Obstet Gynaecol 2007;47:65-69.
  17. Obermair A, Crandon A, Perrin L, Walsh T, Carraro M, Nicklin J. Randomized trial of skin closure after laparotomy for gynaecological surgery.  ANZ J Surg 2007;77(6):460-463.
  18. Smith CJ, Heeren M, Nicklin JL, Perrin LC, Land R, Crandon AJ, Obermair A. Efficacy of routine follow-up in patients with recurrent uterine cancer.  Gynecol Oncol 2007;107:124-129.
  19. Pak SC, Martens M, Bekkers R, Crandon AJ, Land R, Nicklin JL, Perrin LC, Obermair A. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.  Aust NZ J Obstet Gynaecol. 2007;47(6):504-7.
  20. Olsen CM, Nagle CM, Whiteman DC, Purdie DM, Green AC, Webb PM; Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.  Int J Cancer. 2008 Jul 15;123(2):450-6.
  1. Ramus SJ, Vierkant RA, Johnatty SE,et al and Ovarian Cancer Association Consortium. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer. 2008 Jul 15;123(2):380-8.
  1. Spurdle A, Webb P; Australian National Endometrial Cancer Study. Re: Excess of early        onset multiple myeloma in endometrial cancer probands and their relatives suggests common    susceptibility.  Gynecol Oncol. 2008;109(1):153 author reply 154.
  2. Nicklin J, Perrin l, Crandon A, Land R, Nascimento M, Obermair A. Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.  Aust NZ J Obstet Gynaecol  2008;48:447.
  1. Obermair A, Cheuk R, Pak SC, Perrin L, Nicklin J, Crandon A, Land R, Chennakes SK, Janda M, Tripcony L. Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma.  Gynecol Oncol 2008;110:280-285.
  1. DeAmbrosis K, Nicklin J, Yong-Gee S. Basal cell carcinoma of the vulva: a report of four cases.  Australas J Dermatol. 2008;49:213-5.
  1. Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC; Australian Cancer Study Group; Australian Ovarian Cancer Study Group. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.  Eur J Cancer. 2008;44(16):2477-84.
  2. Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group and the Quality of Life Cross-Cultural Meta-Analysis Group. Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.  Qual Life Res 2009;18:381-8.
  3. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode EL, Sellers TA, Vierkant RA, Cunningham JC, Schildkraut JM, Berchuck A, Moorman PG, Iversen ES, Cramer DW, Terry KL, Vitonis AF, Titus-Ernstoff L, Song H, Pharoah PD, Spurdle AB, Anton-Culver H, Ziogas A, Brewster W, Galitovskiy V, Chenevix-Trench G; Australian Cancer Study; Australian Ovarian Cancer Study Group. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.  Br J Cancer. 2009;100(2):412-20.
  4. Kondalsamy-Chennakesavan S, Bouman C, De Jong S, Sanday K, Nicklin J, Land R, Obermair A. Clinical audit in gynecological cancer surgery: development of a risk scoring system to predict adverse events.  Gynecol Oncol 2009;115:329-33.
  5. Gainford MC, Tinker A, Carter J, Petru E, Nicklin J, Quinn M, Elit L, Lenhard M, Friedlander M. Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes.  An Australia New Zealand Gynaecological Oncology Group (ANZGOG) and Gynaecologic Cancer Intergroup (GCIG) study.  Int J Gynecol Cancer. 2010 Jan;20(1):75-81.
  6. Janda M, Gebski V, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, McCartney A, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Walsh T, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede CD, Pather S, Simcock B, Farrell R, Obermair A. Quality of life after laparoscopic hysterectomy for stage I endometrial cancer (LACE): a randomised trial.  Lancet Oncol. 2010;11(8):772-80. 
  1. Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM; Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.  Cancer Causes Control 2010;21(12):2303-8.
  1. Kondalsamy-Chennakesavan S, van Vugt S, Sanday K, Nicklin J, Land R, Perrin L, Crandon A, Obermair A. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer. Int J Gynecol Cancer 2010;20(7):1217-21.
  1. Obermair A, Mileshkin L, Bolz K, Kondalsamy-Chennakesavan S, Cheuk R, Vasey P, Wyld D, Goh J, Nicklin J, Perrin LC, Sykes P, Janda M. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxe with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma.  Gynecol Oncol 2011;120(2):179-84. 
  1. Kondalsamy-Chennakesavan S, Gordon LG, Sanday K, Bouman C, De Jong S, Nicklin J, Land R, Obermair A. Hospital costs associated with adverse events in gynecologic oncology.  Gynecol Oncol 2011;121(1):70-5
  1. Singh P, Nicklin J, Hassall T. Neoadjuvant chemotherapy followed by radical vaginal trachelectomy and adjuvant chemotherapy for clear cell cancer of the cervix: a feasible approach and review.  Int J Gynecol Cancer 2011;21(1):137-40
  1. Nicklin J, Janda M, Gebski V, Jobling T, Land R, Manolitsas T, McCartney A, Nascimento M, Perrin L, Baker J, Obermair A; For the LACE trial investigators. The utility of serum CA-125 in predicting extra-uterine disease in apparent early stage endometrial cancer. Int J Cancer 2011, Sept 14. doi: 10.1002/ijc26433 (epub ahead of print).
  1. Helland A, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, Sheppard KE, Etemadmaghadam D, MeInyk N, Rustgi AK, Phillips WA, Johnsen H, Holm R, Kristensen GB, Birrer MJ, Australian Ovarian Cancer Study Group, Pearson RB, Borresen-Dale AL, Huntsman DG, DeFazio A, Creighton CJ, Smyth GK, Bowtell DD. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.  PLoS One. 2011 Apr13;6(4):e18064.
  1. Singh P, Tripcony L, Nicklin J. Analysis of Prognostic Variables, Development of Predictive Models and Stratification of Risk Groups in Surgically Treated FIGO Early-Stage (IA-IIA) Carcinoma Cervix.  Int J Gynecol Cancer 2012;22(1):115-22.
  1. Rowlands IJ, Weinstein P, Nagle CM, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study (ANECS); Australian Ovarian Cancer Study (AOCS). Season of birth and risk of endometrial cancer.  Asian Pac J Cancer Prev 2011;12(5):1193-6.
  2. Rowlands IJ, Nagle CM, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group; Australian Ovarian Cancer Study Group. Gynecological conditions and the risk of endometrial cancer.  Gynecol Oncol 2011 Dec;123(3):537-41
  3. Healey CS, Ahmed S; ANECS; AOCS Management Group, O’Mara TA, Ferguson K; LES, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F; NSECG, Howarth K, Gorman M, Hodgson S, Tomlinson I; PECS, Yang HP, Lissowska J, Brinton LA, Chanock S, Garcia-Closas M; SASBAC, Hall P, Liu J; SEARCH, Shah M, Pharoah PD, Thompson DJ; WISE, Rebbeck TR, Strom BL, Dunning AM, Easton DF, Spurdle AB. Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study.  Carcinogenesis 2011;32(12):1862-6.
  4. Kondalsamy-Chennakesavan S, Yu C, Kattan MW, Leung Y, Sykes P, Nascimento M, Nicklin J, Perrin L, Crandon A, Chetty N, Land R, Garrett A, Obermair A. Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer. Gynecol Oncol 2012;125(3):520-5
  5. Tan J, Chetty N, Kondalsamy-Chennakesavan S, Crandon A, Garrett A, Land R, Nascimento M, Nicklin J, Perrin L, Obermair A. Validation of the FIGO 2009 staging system for carcinoma of the vulva. Int J Gynecol Cancer. 2012;22(3):498-502.
  6. Kondalsamy-Chennakesavan S, Janda M, Gebski V, Baker J, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede DH, Pather S, Simcock B, Farrell R, Robertson G, Walker G, McCartney A, Obermair A. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial.  Eur J Cancer. 2012 Apr 12.
  7. Obermair A, Janda M, Baker J, Kondalsamy-Chennakesavan S, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede DH, Pather S, Simcock B, Farrell R, Robertson G, Walker G, McCartney A, Gebski V. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: results from a randomised controlled trial. Eur J Cancer. 2012;48(8):1147-53.
  8. Nagle CM, Olsen CM, Ibiebele TI, Spurdle AB, Webb PM; Astralian National Endometrial Cancer Study Group; Australian Ovarian Cancer Study Group Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis. Eur J Nutr. 2013 Mar;52(2):705-15.
  9. Stone JL, Batty T, Nicklin J. Cervical perivascular epithelioid cell tumour (PEComa) of the uterine cervix: cytological findings in a cervical smear.  Cytopathology. 2013 Aug;24(4):272-3.
  10. Samaratunga H, Samaratunga D, Dunglison N, Perry-Keene J, Nicklin J, Delahunt B. Alpha-fetoprotein-producing Carcinoma of the Renal Pelvis Exhibiting Hepatoid and Urothelial Differentiation.  Anticancer Research. 2012;32:4987-4992.
  11. Kirchhoff T, Gaudet MM, Antoniou AC, McGuffog L, Humphreys MK, Dunning AM, Bojesen SE, Nordestgaard BG, Flyger H, AOCS Study Group, Chenevix-Trench G, Easton DF; BCAC/CIMBA, et al. Breast cancer risk and 6q22.33:combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.  PLoS One. 2012;7(6):e35706. doi: 10.1371/journal.pone.0035706. Epub 2012 Jun 29.
  12. Garcia-Dios DA, Lambrechts D, Coenegrachts L, Vandenput I, Capoen A, Webb PM, Ferguson K; ANECS, Akslen LA, Claes B, Vergote I, Moerman P, Van Robays J, Marcickiewicz J, Salvesen HB, Spurdle AB, Amant F. High-throughput interrogation of PIK3CA, PTEN, KRAS,FBXW7 and TP53 mutations in primary endometrial carcinoma.  Gynecol Oncol. 2013; 128(2):327-34.
  13. Baumbusch LO, Helland Å, Wang Y, Liestøl K, Schaner ME, Holm R, Etemadmoghadam D, Alsop K, Brown P; Australian Ovarian Cancer Study Group, Mitchell G, Fereday S, DeFazio A, Bowtell DD, Kristensen GB, Lingjærde OC, Børresen-Dale AL. High levels of genomic aberrations in serous ovarian cancers are associated with better survival.  PLoS One 2013;8(1): e54356.
  14. Jordan S, Steer C, DeFazio A, Quinn M, Obermair A, Friedlander M, Francis J, O’Brien S, Goss G, Wyld D, Australian Ovarian Cancer Study Group, Webb P; Ovarian Cancer Patterns of Care Study Group. Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer — a population based study.  Gynecol Oncol. 2013 May;129(2):310-7
  15. Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, et al. Obestiy and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer. 2013 Mar 22;20(2):251-62
  16. Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, Aben KK, Anton-Culver H, Antonenkova N, Antoniou AC, Armasu SM; Australian Cancer Study; Australian Ovarian Cancer Study et al. Identification and molecular characterization of a new ovarian susceptibility locus at 17q21.13. Nat Commun. 2013;4:1627
  17. Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M; PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Australian Ovarian Cancer Study Group, et al. Epigenetic analysis leads to identification of HNF1B as subtype-specific gene for ovarian cancer. Nat Commun. 2013;4:1628.
  18. Nagle CM, Marquart L, Bain CJ, O’Brien S, Lahmann PH, Quinn M, Oehler MK, Obermair A, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group. Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer. Eur J Cancer. 2013 Aug;49(12):2717-26.
  19. George J, Alsop K, Etemadmoghadam D, Hondow H, Mikeska T, Dobrovic A, deFazio A; Australian Ovarian Cancer Study Group, Smyth GK, Levine DA, Mitchell G, Bowtell DD. Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations. Clin Cancer Res 2013 Jul 1;19(13);3473-84.
  20. Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM; Australian Cancer Study (Ovarian Cancer), et al. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prev Res (Phila). 2013 Aug;6(8):811-21.
  21. Hackethal A, Brennan DJ, Land R, Nascimento M, Nicklin J, Obermair A. Feasibility and outcomes of ureteroureterostomy and extravesical ureteroneocystostomy as a part of radical surgery for infiltrating gynecological disease. Int J Gynecol Cancer2013Jul;23(6):1139-45.
  22. Dong Y, Loessner D, Irving-Rodgers H, Obermair A, Nicklin JL, Clements JA. Metastasis of ovarian cancer is mediated by kallikrein related pepridases. Clin Exp Metastasis 2014 Jan;31(1):135-47.
  23. Hedditch EL, Gao B, Russell AJ, Lu Y, Emmanuel C, BeesleyJ, Johnatty SE, Chen X, Harnett P, George J; Australian Ovarian Cancer Study Group, et al.  ABCA transporter gene expression and poor outcome in epithelial ovarian cancer. J Natl Cancer Inst. 2014 Jun 23;106(7).
  24. Rowlands IJ, Lee C, Beesley VL, Webb PM; Australian National Endometrial Cancer Study Group. Predictors of sexual well-being after endometrial cancer: results of a national self-report survey.  Support Care Cancer. 2014 Oct;22(10):2715-23
  25. Rowlands IJ, Beesley VL, Janda M, Hayes SC, Obermair A, Quinn MA, Brand A, Leung Y, McQuire L, Webb PM, Australian National Endometrial Cancer Study Group. Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer. Gynecol Oncol. 2014 May;133(2):314-8
  26. Faber-Swensson AP, Perrin LC,Nicklin   Radical trachelectomy for early stage cervical cancer: the Queensland experience. Aust NZ J Obstet Gynaecol 2014;54(5):450-2
  27. Brennan DJ, Hackethal A, Metcalf AM, Coward J, Ferguson K, Oehler MK, Quinn MA, Janda M, Leung Y, Freemantle M; ANECS Group, Webb PM, Spurdle AB, Obermair A. HE4 as a prognostic marker in endometrial cancer – a population based study.  Gynecol Oncol. 2014 Jan;132(1):159-65.
  28. Faber-Swensson AP, Perrin LC,Nicklin   Re:  Radical trachelectomy for early stage cervical cancer: the Queensland experience ANZJOG 2014;54(5):450-452. Aust NZ J Obstet Gynaecol 2015;55(3):298-9.
  29. Gao B, Russell A, Beesley J, Chen XQ, Healey S, Henderson M, Wong M, Emmanuel C, Galletta L, Johnatty SE, Bowtell D; Australian Ovarian Cancer Study Group, Haber M, Norris M, Harnett P, Chenevix-Trench G, Balleine RL, deFazio A. Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide poylmorphisms in ovarian cancer. Sci Rep 2014; May 9:4:4669.
  30. Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group, et al. Whole-genome characterization of chemoresistant ovarian cancer.  Nature. 2015 May 28;521(7553):489-94.
  31. Baker J, Janda M, Graves N, Bauer J, Banks M, Garrett A, Chetty N, Crandon AJ, Land R, Nascimento M, Nicklin JL, Perrin LC, Obermair A. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial.  Gynecol Oncol. 2015 Jun;137(3):516-22.
  32. Hackethal A, Brennan D, Rao A, Land R, Obermair A, Nicklin J, Garrett A, Nascimento M, Crandon A, Perrin L, Chetty N. Consideration for safe and effective gynaecological laparoscopy in the obese patient.  Arch Gynecol Obstet. 2015 Jul;292(1):135-41.
  33. Beesley VL, Rowlands IJ, Hayes SC, Janda M, O’Rourke P, Marquart L, Quinn MA, Spurdle AB, Obermair A, Brand A, Oehler MK, Leung Y, McQuire L, Webb PM; Australian National Endometrial Cancer Study Group. Incidence, risk factors and estimates of a woman’s risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer.  Gynecol Oncol 2015 Jan;136(1):87-93.
  1. Khan S, Greco D, Michailidou K, Australian Ovarian Cancer Study Group, et al. MicroRNA related polymorphisms and breast cancer risk. PLoS 2014 Nov 12;9(11)
  1. Painter JN, O’Mara TA, Batra J, Australian National Endometrial Cancer Study Group (ANECS), et al. Fine-mapping of the HNF1B multicancer locus indentifies candidate variants that mediate endometrial cancer risk.  Hum Mol Genet. 2015 Mar 1;24(5):1478-92
  1. Rowlands IJ, Janda M, McKinnon L, Webb PM, Beesley VL; Australian National Endometrial Cancer Study Group. Prevalence, predictors, and correlates of supportive care needs among women 3-5 years after a diagnosis of endometrial cancer.  Support Care Cancer. 2015 May;23(5):1205-14
  1. Kondrashova O, Love CJ, Hsu AL, Australian Ovarian Cancer Study (AOCS) Group, et al. High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq. PLoS One Nove16:10(11):e0143006.doi:10.1371/journal.pone.0143006. eCollection 2015
  1. Pharoah PD, Song H, Dicks E, Australian Ovarian Cancer Study Group, et al.  PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. J Natl Cancer Inst. 2016 Jan 27;108(3). pii: djv347. doi: 10.1093/jnci/djv347. Print 2016 Mar.
  1. McGrath S, Nicklin J. Clinicopathological study of ovarian carcinoid tumours.  Aust NZ J Obstet Gynaecol 2016;56(5):508-513.
  2. Fogarty SJ, Hart G, Nicklin J, Venkatesh B, Boyne N, Wong DC, Stone JL, Rainbird AJ. Intracardiac Leiomyomatosis – an Unusual Cause of Syncope in a Middle-Aged Woman.  Heart Lung Circ.  2016; Sep 17 . pii: S1443-9506(16)31586-4.
  3. Janda M, Gebski V, Davies LC, Forder P, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede CD, Pather S, Simcock B, Farrell R, Robertson G, Walker G, Armfield NR, Graves N, McCartney AJ, Obermair A. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial.  JAMA 2017 Mar 28;317(12):1224-1233
  4. Playdon MC, Nagle CM, Ibiebele TI, Ferrucci LM, Protani MM, Carter J, Hyde SE, Neesham D, Nicklin JL, Mayne ST, Webb PM. Pre-diagnosis diet and survival after a diagnosis of ovarian cancer.  Br J Cancer. 2017 May 2. doi: 10.1038/bjc.2017.120
  5. Morgan EL, Sanday K, Budd A, Hammond IG, Nicklin JL. Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?  Aust NZ J Obstet Gynaecol 2017;57:469-472.
  6. Nicklin JL, McGrath S, Tripcony L, Garrett A, Land R, Tang A, Perrin L, Chetty N, Jagasia N, Crandon AJ, Nascimento M, Walker G, Sanday K, Obermair A. The shift toward neo-adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population-based setting: Impact on clinical outcomes. Aust N Z J Obstet Gynaecol. 2017 Jul 18. doi: 10.1111/ajo.12665. [Epub ahead of print]
  1. Nicklin JL. The future of robotic-assisted laparoscopic gynaecological surgery in Australia – A time and a place for everything. Aust N Z J Obstet Gynaecol. 2017;57(5):493-498.
  2. Block MS, Australian Ovarian Cancer Study Group, et al. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc. 2018 Mar;93(3): 307-320
  3. Nicklin J, Morgan EL. Authors reply:  Cervical cancer in women under 25 years of age in Queensland, Australia:  To what extent is the diagnosis made by screening cytology? Aust NZ J Obstet Gynaecol.  2018 June;58(3):E6
  4. Kondrashova O, The Australian Ovarian Cancer Study, et al. Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.  Nat Commun. 2018 Sep 28;9(1):3970. doi: 10.1038/s41467-018-05564-z
  5. Robertson JA, Sunday K, Nicklin J. Malignant ovarian germ cell tumours in the post-menopausal population.  Aust NZ J Obstet Gynaecol 2018; Oct 2. doi: 10.1111/ajo.12897.
  6. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N, Isla D, Tamura M, Zhu T, Robledo KP, Gebski V, Asher R, Behan V, Nicklin JL, Coleman RL, Obermair A. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med 2018;Oct 31 doi:10.1056/NEJMoa1806395.